# IRulya Therapeutics Inc.: Form 8-K, filed Nov 14, 2024

- Company: [IRulya Therapeutics Inc.](/companies/irla.md) (CIK 1662774)
- Form: 8-K
- Filed: 2024-11-14
- Accepted by EDGAR: Nov 14, 2024, 06:55 ET
- Period: 2024-11-12
- Accession: 0001662774-24-000013
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1662774/000166277424000013/qncx-20241112.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1662774/000166277424000013/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1662774/000166277424000013/qncx-20241112.htm

Filed Nov 14, 2024.
Source: SEC EDGAR, the filing index for accession 0001662774-24-000013. Last ingested by Listed: Nov 15, 2026, 02:27 ET. No prices; not investment advice.
